"Cytokines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
| Descriptor ID |
D016207
|
| MeSH Number(s) |
D12.644.276.374 D12.776.467.374 D23.529.374
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cytokines".
Below are MeSH descriptors whose meaning is more specific than "Cytokines".
This graph shows the total number of publications written about "Cytokines" by people in this website by year, and whether "Cytokines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 6 | 7 | 13 |
| 1996 | 2 | 6 | 8 |
| 1997 | 8 | 2 | 10 |
| 1998 | 1 | 5 | 6 |
| 1999 | 8 | 4 | 12 |
| 2000 | 3 | 5 | 8 |
| 2001 | 4 | 8 | 12 |
| 2002 | 3 | 12 | 15 |
| 2003 | 5 | 17 | 22 |
| 2004 | 5 | 14 | 19 |
| 2005 | 7 | 22 | 29 |
| 2006 | 3 | 15 | 18 |
| 2007 | 6 | 9 | 15 |
| 2008 | 12 | 9 | 21 |
| 2009 | 8 | 21 | 29 |
| 2010 | 11 | 15 | 26 |
| 2011 | 10 | 17 | 27 |
| 2012 | 9 | 16 | 25 |
| 2013 | 6 | 22 | 28 |
| 2014 | 2 | 17 | 19 |
| 2015 | 3 | 26 | 29 |
| 2016 | 8 | 17 | 25 |
| 2017 | 8 | 24 | 32 |
| 2018 | 8 | 19 | 27 |
| 2019 | 8 | 15 | 23 |
| 2020 | 11 | 15 | 26 |
| 2021 | 6 | 18 | 24 |
| 2022 | 2 | 20 | 22 |
| 2023 | 0 | 13 | 13 |
| 2024 | 3 | 8 | 11 |
| 2025 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytokines" by people in Profiles.
-
Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling. Neurol Neuroimmunol Neuroinflamm. 2025 Jul; 12(4):e200403.
-
Associations of Serum Inflammatory Biomarkers During Pregnancy With Placental Pathology and Placental Gene Expression at Delivery. Am J Reprod Immunol. 2025 Apr; 93(4):e70062.
-
Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in RUNX1-familial platelet disorder. Sci Transl Med. 2025 Jan 08; 17(780):eadn9832.
-
Targeting molecular pathways to control immune checkpoint inhibitor toxicities. Trends Immunol. 2025 Jan; 46(1):61-73.
-
Regulatory roles of NAMPT and NAD+ metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment. Redox Biol. 2024 Dec; 78:103411.
-
Nuclear Factor ?B Signaling Deficiency in CD11c-Expressing Phagocytes Mediates Early Inflammatory Responses and Enhances Mycobacterium tuberculosis Control. J Infect Dis. 2024 Aug 16; 230(2):336-345.
-
Differential Secretomes of Processed Adipose Grafts, the Stromal Vascular Fraction, and Adipose-Derived Stem Cells. Stem Cells Dev. 2024 Sep; 33(17-18):477-483.
-
Palmitoylation at a conserved cysteine residue facilitates gasdermin D-mediated pyroptosis and cytokine release. Proc Natl Acad Sci U S A. 2024 Jul 16; 121(29):e2400883121.
-
Alendronate modulates cytokine responses in healthy young individuals after BCG vaccination. Immunol Lett. 2024 06; 267:106851.
-
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nat Commun. 2024 Feb 06; 15(1):974.